
As resin-based restoratives replace amalgam, concerns about bisphenol A (BPA) release have grown. Despite minimal exposure from dental sources, BPA's endocrine-disrupting potential—even at ultra-low doses—raises regulatory alarm. This review examines BPA release data, highlights methodological gaps, and proposes mitigation strategies, offering insights for clinicians, researchers, and regulators amid evolving safety standards and material innovations.
Like
Save
Share